Pediatrix Medical Group (MD) PT Raised to $10 at Truist Securities

Truist Securities analyst David MacDonald raised the price target on Pediatrix Medical Group (NYSE: MD) to $10.00 (from $8.00) while maintaining a Hold rating.

The analyst commented: "We have adjusted our estimates to reflect 2Q results, raising our 2024E and 2025E adjusted EBITDA to $208.2M and $218.0M (vs. prior $201.1M and $208.0M, respectively). We maintain our Hold rating and are raising our price target to $10 (vs. prior $8)."

You May Also Be Interested In

• Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
• NAHB housing market index rises to 35 in August from 34
• Stifel on EyePoint Inc. (EYPT): 'we think these data bode well for LUCIA (expected October) barring another unusual asymmetry'